Arrow Financial’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-500
| Closed | -$77.6K | – | 203 |
|
|
2024
Q3 | $77.6K | Hold |
500
| – | – | 0.01% | 204 |
|
|
2024
Q2 | $68.4K | Hold |
500
| – | – | 0.01% | 200 |
|
|
2024
Q1 | $66.6K | Hold |
500
| – | – | 0.01% | 195 |
|
|
2023
Q4 | $68.9K | Hold |
500
| – | – | 0.01% | 195 |
|
|
2023
Q3 | $60.9K | Hold |
500
| – | – | 0.01% | 196 |
|
|
2023
Q2 | $70.3K | Hold |
500
| – | – | 0.01% | 189 |
|
|
2023
Q1 | $70.7K | Hold |
500
| – | – | 0.01% | 193 |
|
|
2022
Q4 | $78K | Hold |
500
| – | – | 0.01% | 186 |
|
|
2022
Q3 | $61K | Hold |
500
| – | – | 0.01% | 198 |
|
|
2022
Q2 | $66K | Hold |
500
| – | – | 0.01% | 197 |
|
|
2022
Q1 | $68K | Hold |
500
| – | – | 0.01% | 199 |
|
|
2021
Q4 | $87K | Hold |
500
| – | – | 0.01% | 186 |
|
|
2021
Q3 | $73K | Hold |
500
| – | – | 0.01% | 198 |
|
|
2021
Q2 | $66K | Hold |
500
| – | – | 0.01% | 198 |
|
|
2021
Q1 | $64K | Hold |
500
| – | – | 0.01% | 198 |
|
|
2020
Q4 | $60K | Hold |
500
| – | – | 0.01% | 190 |
|
|
2020
Q3 | $57K | Hold |
500
| – | – | 0.01% | 190 |
|
|
2020
Q2 | $57K | Hold |
500
| – | – | 0.01% | 196 |
|
|
2020
Q1 | $40K | Hold |
500
| – | – | 0.01% | 211 |
|
|
2019
Q4 | $53K | Sell |
500
-150
| -23% | -$15.6K | 0.01% | 218 |
|
|
2019
Q3 | $70K | Hold |
650
| – | – | 0.01% | 202 |
|
|
2019
Q2 | $66K | Hold |
650
| – | – | 0.01% | 212 |
|
|
2019
Q1 | $58K | Hold |
650
| – | – | 0.01% | 214 |
|
|
2018
Q4 | $54K | Hold |
650
| – | – | 0.01% | 206 |
|
|
2018
Q3 | $70K | Hold |
650
| – | – | 0.01% | 205 |
|
|
2018
Q2 | $71K | Hold |
650
| – | – | 0.02% | 192 |
|
|
2018
Q1 | $65K | Hold |
650
| – | – | 0.02% | 195 |
|
|
2017
Q4 | $64K | Hold |
650
| – | – | 0.01% | 194 |
|
|
2017
Q3 | $61K | Hold |
650
| – | – | 0.01% | 198 |
|
|
2017
Q2 | $72K | Hold |
650
| – | – | 0.02% | 194 |
|
|
2017
Q1 | $64K | Hold |
650
| – | – | 0.02% | 200 |
|
|
2016
Q4 | $60K | Hold |
650
| – | – | 0.01% | 202 |
|
|
2016
Q3 | $55K | Hold |
650
| – | – | 0.01% | 206 |
|
|
2016
Q2 | $53K | Hold |
650
| – | – | 0.01% | 211 |
|
|
2016
Q1 | $46K | Hold |
650
| – | – | 0.01% | 224 |
|
|
2015
Q4 | $46K | Hold |
650
| – | – | 0.01% | 213 |
|
|
2015
Q3 | $40K | Hold |
650
| – | – | 0.01% | 209 |
|
|
2015
Q2 | $47K | Hold |
650
| – | – | 0.01% | 209 |
|
|
2015
Q1 | $50K | Hold |
650
| – | – | 0.01% | 206 |
|
|
2014
Q4 | $44K | Hold |
650
| – | – | 0.01% | 207 |
|
|
2014
Q3 | $39K | Hold |
650
| – | – | 0.01% | 234 |
|
|
2014
Q2 | $38K | Hold |
650
| – | – | 0.01% | 233 |
|
|
2014
Q1 | $38K | Hold |
650
| – | – | 0.01% | 226 |
|
|
2013
Q4 | $35K | Hold |
650
| – | – | 0.01% | 220 |
|
|
2013
Q3 | $40K | Hold |
650
| – | – | 0.01% | 208 |
|
|
2013
Q2 | $39K | Buy |
+650
| New | +$38.7K | 0.01% | 198 |
|
Other funds holding DGX
DSA
Arrow Financial's DGX Position: Q4 2024 in Review
Arrow Financial sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 500 shares — an estimated $77.6K sold.
Arrow Financial first reported a position in DGX in Q2 2013 and held it in 46 quarters. The position peaked at $87K in Q4 2021. 897 funds tracked by Wall St. Rank hold DGX as of Q4 2024.
- Arrow Financial reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
- Arrow Financial sold 500 Quest Diagnostics shares in Q4 2024, an estimated $77.6K.
- Arrow Financial first reported a position in Quest Diagnostics in Q2 2013 and held it in 46 quarters.
- Arrow Financial's Quest Diagnostics position peaked at $87K in Q4 2021.
- 897 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.
Based on Arrow Financial's 13F filing for Q4 2024, filed 14 Feb 2025.